UNSPSC 51152035: Mephenesin

This classification denotes a muscle relaxant with the molecular formula C10H14O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7B8PIR2954, chemically known as 1,2-propanediol, 3-(o-tolyloxy)- but generally known as mephenesin, which bears US NIH Compound Identifier 4059. European Medicines Agency schedules Mephenesin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08746MIG. The term MEPHENESIN is an International Non-Proprietary Name.

UNSPSC 51152035 Mephenesin is a Commodity code representing pharmaceutical products, though the recent state and local activity under this code does not align with mephenesin procurement; instead, Seminole County, Florida has posted solicitations for naloxone and drug deactivation systems. State and local governments using this code appear to be sourcing emergency medical and public health supplies—specifically opioid-overdose reversal agents and controlled-substance disposal systems—primarily through county public-health departments and emergency-services entities. These are typically procured as part of community health and harm-reduction initiatives with defined annual volumes and quarterly delivery schedules.

Seminole County, Florida is the primary recent issuing body active under this code designation. The county released an IFB (Invitation for Bid) numbered IFB60459723LAS on June 30, 2026, seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB carried a response deadline of July 26, 2023, with delivery and shipping costs to be included in bids. The contract structure includes an initial two-year term with one optional one-year renewal, drug-free workplace certification, E-Verify compliance, and standard commercial general and professional liability insurance requirements. Potential FEMA funding introduces federal compliance obligations including Clean Air Act and Federal Water Pollution Control Act adherence. The procurement does not specify set-aside designations for disadvantaged enterprises.